Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats

Carcinogenesis

Volumn 17, Issue 7, 1996, Pages 1451-1457

  Murrill, W Britton ^a   Brown, Nadine M ^a   Zhang, Jun Xuan ^a   Manzolillo, Patricia A ^a   Barnes, Stephen ^a   Lamartiniere, Coral A ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; DIMETHYL SULFOXIDE; DIMETHYLBENZ[A]ANTHRACENE; ESTRADIOL; GENISTEIN; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DIFFERENTIATION; DRUG BLOOD LEVEL; ESTRUS CYCLE; FEMALE; MAMMARY GLAND; NONHUMAN; OOCYTE; OVARY FOLLICLE; PREPUBERTY; PRIORITY JOURNAL; RAT; SOYBEAN; SUBCUTANEOUS DRUG ADMINISTRATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADENOCARCINOMA; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CORPUS LUTEUM; DIMETHYL SULFOXIDE; ESTRUS; FEMALE; GENISTEIN; ISOFLAVONES; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; OOCYTES; OVARIAN FOLLICLE; RATS; RATS, SPRAGUE-DAWLEY; SEXUAL MATURATION; TIME FACTORS;

EID: 0029957108     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.7.1451     Document Type: Article

References (54)

1. The American Cancer Society (1994) Cancer Facts and Figures. Atlanta, GA.
2. Kuratsune, M., Ikeda, M., Nakamura, Y. and Hirohata, T. (1987) A cohort study on mortality of 'Yusho' patients: a preliminary report. Int. Symp. Princess Takamutsa Cancer Res. Fund., 18, 61-66.
3. Manz, A., Berger, J., Dwyer, J.H., Flesch-Janys, D., Nagel, S. and Waltsgott, H. (1991) Cancer mortality among workers in a chemical plant contaminated with dioxin. Lancet, 338, 959-964.
4. Lee, H.P., Gourley, L., Duffy, S.W., Esteve, J., Lee, J. and Day, N.E. (1991) Dietary effects on breast cancer risk in Singapore. Lancet, 337, 1197-1200.
5. Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., Hamalainen, E., Hasegawa, T. and Okada, H. (1991). Urinary excretion of ligands and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr., 54, 1093-1100.
6. Setchell, K.D.R., Borriello, S.P., Hulme, P., Kirk, D.N. and Axelson, M. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr., 40, 569-578.
7. Adlercreutz, H. (1990) Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest., 50 (201), 3-23.
8. Barnes, S., Grubbs, C., Setchell, K.D.R. and Carlson, J. (1990) Soybeans inhibit mammary tumors in models of breast cancer. Prog. Clin. Biol. Res., 347, 239-253.
9. Lamartiniere, C.A., Moore, J., Holland, M. and Barnes, S. (1995) Neonatal genistein chemoprevents mammary cancer. Proc. Soc. Exp. Biol. Med., 208, 120-123.
10. Lamartiniere, C.A., Moore, J.B., Brown, N.M., Thompson, R., Hardin, M.J. and Barnes, S. (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis, 16, 2833-2840.
11. Barnes, S., Kirk, M. and Coward, L. (1994) Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J. Agric. Food Chem., 42, 2466-2474.
12. Shutt, D.A. and Cox, R.I. (1972) Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J. Endocrinol., 52, 299-310.
13. Mathieson, R.A. and Kitts, W.D. (1980) Binding of phytoestrogen and estradiol-17β by cytoplasmic receptors in the pituitary gland and hypothalamus of the ewe. J. Endocrinol., 85, 317-325.
14. Cheng, E., Story, C.D., Yoder, L., Hale, W.H. and Burroughs, W. (1980) Estrogenic activity of isoflavone derivatives extracted and prepared from soybean oil meal. Science, 118, 164-165.
15. Bickoff, E.M., Livingston, A.L., Hendrickson, A.P. and Booth, A.N. (1962) Relative potencies of several estrogen-like compounds found in forages. J. Agric. Food Chem., 10 (5), 410-412.
16. Folman, Y. and Pope, G.S. (1966) The interaction in the immature mouse of potent estrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J. Endocrinol., 34, 215-225.
17. Martin, P.M., Horowitz, K.B., Ryan, D.S. and McGuire, W.L. (1978) Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology, 103, 1860-1867.
18. Okura, A., Arakawa, H., Oka, H., Yoshinari, T. and Monden, Y. (1988) Effect of genistein on topoisomerase activity and on the growth of [Val12] Ha-ras-transformed N1H 3T3 cells. Biochem. Biophys. Res. Commun., 157, 183-189.
19. Tripathi, Y.B., Lim, R.W., Fernandez-Gallardo, S., Kandala, J.C. Guntaka, R.V. and Shukla, S.D. (1992) Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. Biochem. J., 286, 527-533.
20. Dean, N.M., Kanemitsu, M. and Boynton, A.L. (1989) Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phospholipid derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem. Biophys. Res. Commun., 165, 795-801.
21. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M. and Fukami, Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592-5595.
22. Wei, H., Bowen, R., Cai, Q., Barnes, S. and Wang, Y. (1995) Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208, 124-130.
23. Brown, N.M. and Lamartiniere, C.A. (1995) Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environ. Health Perspect., 103, 708-713.
24. Kiguchi, K., Constantinou, A.I. and Huberman, E. (1990) Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun., 2, 271-277.
25. Watanabe, T., Kondo, K. and Oishi, M. (1991) Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res., 51, 764-768.
26. Kondo, K., Tsuneizumi, K., Watanabe, T. and Oishi, M. (1991) Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res., 51, 5398-404.
27. Miller, D.R., Lee, G.M. and Maness, P.F. (1993) Increased neunte outgrowth induced by inhibition of protein tyrosine kinase activity in PC12 pheochromocytoma cells. J. Neurochem., 60, 2134-2144.
28. Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R. and Schweigerer, L. (1995) Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutrition, 125 (Suppl. 3), 790S-797S.
29. Uckun, F.M., Evans, W.E., Forsyth, C.J., Waddick, K.G., Ahlgren, L.T., Chelstrom, L.M., Burkhardt, A., Bolen, J. and Myers, D.E. (1995) Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science, 267, 886-891.
30. Coward, L., Barnes, N.C., Setchell, K.D.R. and Barnes, S. (1993) Genistein and daidzein, and their β-glycoside conjugates: anti-tumor isoflavones in soybean foods of the American and Asian diets. J. Agric. Food Sci., 41, 1961-1967.
31. Boorman, G., Eustin, S., Elwell, M., Montgomery, C. and MacKenzie, W. (1990) Pathology of the Fischer Rat: Reference and Atlas. Academic Press, New York.
32. Russo, I.H. and Russo, J. (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenzanthracene. J. Natl Cancer Inst., 61, 1439-1449.
33. Russo, J. and Russo, I.H. (1978) DNA labelling index and structure of the rat mammary gland as determinants of its susceptibility to carcinogenesis. J. Natl Cancer Inst., 61, 1451-1459.
34. Russo, I.H., Tewari, M. and Russo, J. (1988) Morphology and development of the rat mammary gland. In Jones, T.C., Konishi, Y. and Mohr, U. (eds), Integument and Mammary Gland, Monograph Series on the Pathology of Laboratory Animals. Springer-Verlag, Berlin.
35. Galbraith, W. and Marshall, P.N. (1984) Studies on papanicolaou staining. III. Quantitative investigations of orangeophilia and cyanophilia. Stain Technol., 59, 133-142.
36. Hafez, E.S.E. (1970) Reproduction and Breeding Techniques for Laboratory Animals. Lea and Febiger, Philadelphia.
37. Heinrichs, W.L. (1985) Current laboratory approaches for assessing female reproductive toxicity. Reprod. Toxicol., 95-107.
38. Plowchalk, D.R., Smith, B.J. and Mattison, D.R. (1993) Assessment of toxicity to the ovary using follicle quantitation and morphometrics. Methods Toxicol., 3B, 57-68.
39. Kokoska, S.M., Hardin, J.M., Grubbs, C.J. and Hsu, C. (1993) The statistical analysis of cancer inhibition/promotion experiments. Anticancer Res., 13, 1357-1365.
40. Freedman, L.S., Steele, V. and Kelloff, G. (1990) Statistical guidelines for the analysis of data from chemoprevention experiments in rodent tumor models. Internal Report Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, M.D.
41. Freedman, L.S., Midthune, D.N., Brown, C.C., Steele, V. and Kelloff, G.J. (1993) Statistical analysis of animal cancer chemoprevention experiments. Biometrics, 49, 259-268.
42. Welsch, C.W. (1985) Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45, 3415-3443.
43. Makela, S., Davis, V.L., Tally, W.C., Korkman, J., Salo, L., Vihko, R., Santti, R. and Korach, K.S. (1994) Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect., 102, 572-578.
44. Nagasawa, H., Yanai, R. and Taniguchi, H. (1976) Importance of mammary gland DNA synthesis on carcinogen induced mammary tumorigenesis in rats. Cancer Res., 36, 2223-2226.
45. Russo, J. and Russo, J.H. (1987) Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab. Invest., 57, 112-137.
46. Berenblum, I. (1954) A speculative review: the probable nature of promoting action, and its significance in the understanding of the mechanism of carcinogenesis. Cancer Res., 14, 471-476.
47. Russo, J. and Russo, I.H. (1980) Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res., 40, 2677-2687.
48. Cassidy, A., Bingham, S. and Setchell, K.D. (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60, 333-340.
49. Treloar, A.E., Boynton, R.E., Behn, B.G. and Brown, B.W. (1970) Variation of the human menstrual cycle through reproductive life. Int. J. Fertil., 12, 77-126.
50. Ferguson, D.J. and Anderson, T.J. (1981) Morphological evaluation of cell turn-over in relation to the menstrual cycle in the 'resting' human breast. Br. J. Cancer, 44, 177-181.
51. Olsson, H., Landin-Olsson, M. and Gullberg, B. (1983) Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. J. Natl Cancer Inst., 70, 17-20.
52. MacMahon, B., Cole, P., Lin, T.M. et al. (1970) Age at first birth and breast cancer risk. Bull. World Health Organ., 43, 209-221.
53. Shellabarger, C.J. and Soo, V.A. (1973) Effects of neonatally administered sex steroids on 7,12-dimethylbenz[a]anthracene-induced mammary neoplasia in rats. Cancer Res., 33, 1567-1569.
54. Nagasawa, H., Yanai, R., Shodono, M., Nakamura, T. and Tanabe, Y. (1974) Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17β level in rats. Cancer Res., 34, 2643-2646.